The University of Yaoundé II-IFPMA Chair
The UYII-IFPMA Chair on “Health and Globalization: Laws, Policies and Market” is an initiative by the University of Yaoundé II, Cameroon, and IFPMA.
Overview
The Chair on “Health and Globalization: Laws, Policies, and Market” aims to become a focal point for global health topics, enable a local African perspective, and contribute to the development of further understanding and dialogue on rules, policies, and market dynamics.
Its mission is to develop, organize, and conduct innovative and in-depth research activities and projects in the field of global health.
The Chair is a thematic and interdisciplinary research and training program launched on February 16, 2021, consisting of contributions from professors, PhD students and administrative students. Its objective is to develop the University of Yaoundé II into a high-tech cluster for social sciences in Africa.
Chair functions
A reference center
for basic and applied research in the social sciences on global health issues
An expert body
with public authorities, specialized agencies, development partners, and private initiatives
A structure
to produce innovative knowledge and the development of emerging knowledge in global health
A framework
for the promotion of fundamental and applied research in global health
H3D Foundation
The H3D Foundation supports drug innovation and science in Africa through initiatives to strengthen capacity, partnerships, and fundraising for African researchers and research centers. IFPMA and member companies partner with H3D Foundation to promote health innovation in Africa.
Support the Chair
The Chair “Health and Globalization: Laws, Policies and Market” is a significant development for health in Africa. Find out how you can support this initiative.
Other partnerships and alliances
See all
The International Council for Harmonisation (ICH)
As a Standing Observer of ICH, IFPMA along with other ICH Members and Observers, has an important role in promoting global convergence toward ICH regulatory standards and their harmonized interpretation.
INTREPID Alliance
INTREPID Alliance exists to accelerate the development of new treatments for emerging viral pandemic agents through coordinated early science and R&D, policy and advocacy and stakeholder engagement. INTREPID Alliance members collectively bring expertise in drug discovery, antiviral R&D and medicine manufacturing.
Navigating Innovation & Research Opportunities (NIRO)
Helping actors in research and innovation identify opportunities within and beyond the European Union